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Background: Accurate and reproducible behavioral tests in animal models are of major importance in the
development and evaluation of new therapies for central nervous system disease. In this study we investigated for
the first time gait parameters of rat models for Parkinson’s disease (PD), Huntington’s disease (HD) and stroke using
the Catwalk method, a novel automated gait analysis test. Static and dynamic gait parameters were measured in
all animal models, and these data were compared to readouts of established behavioral tests, such as the cylinder
test in the PD and stroke rats and the rotarod tests for the HD group.
Results: Hemiparkinsonian rats were generated by unilateral injection of the neurotoxin 6-hydroxydopamine in the
striatum or in the medial forebrain bundle. For Huntington’s disease, a transgenic rat model expressing a truncated
huntingtin fragment with multiple CAG repeats was used. Thirdly, a stroke model was generated by a
photothrombotic induced infarct in the right sensorimotor cortex. We found that multiple gait parameters were
significantly altered in all three disease models compared to their respective controls. Behavioural deficits could be
efficiently measured using the cylinder test in the PD and stroke animals, and in the case of the PD model, the
deficits in gait essentially confirmed results obtained by the cylinder test. However, in the HD model and the
stroke model the Catwalk analysis proved more sensitive than the rotarod test and also added new and more
detailed information on specific gait parameters.
Conclusion: The automated quantitative gait analysis test may be a useful tool to study both motor impairment
and recovery associated with various neurological motor disorders.
Background
Multiple neurodegenerative and vascular central nervous
system (CNS) diseases are characterized by motor defi-
cits. For many of these diseases, no satisfactory neuro-
protective or neuroregenerative therapies are available
thus far. Therefore, the development of appropriate ani-
mal models for CNS motor disorders and the adequate
evaluation of novel therapies in these animal models is
an active field of preclinical research. In addition to the
emerging non-invasive molecular and anatomical ima-
ging techniques to visualize and quantify deficits and
recovery in these disorders, behavioral testing is fre-
quently the primary experimental readout to assess
therapeutic effects. For this reason, sensitive, reproduci-
ble, time-efficient and easily applicable behavioral tests
for existing or newly generated animal models are war-
ranted. The present study has focused on animal models
for three different motor disorders: the 6-hydroxydopa-
mine (6-OHDA) rat models of Parkinson’s disease (PD),
a transgenic rat model of Huntington’s disease (HD)
and a photothrombotic cortical lesion model of stroke.
PD is the most common neurodegenerative movement
disorder whose hallmark feature is an extensive and pro-
gressive degeneration of dopaminergic neurons in the
pars compacta of the substantia nigra [1]. Among the
most widely used and longest established animal models
of PD are the dopaminergic neuron lesion models
employing 6-hydroxydopamine (6-OHDA) [2,3]. Of
these, the unilateral infusion of 6-hydoxydopamine
(6-OHDA) in the basal ganglia at the level of the stria-
tum or ascending dopaminergic fibers leads to unilateral
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of the body contralateral to the lesion [4].
Next to toxin-induced HD animal models such as the
administration of 2,3-pyridinedicarboxylic acid (quinoli-
nic acid), transgenic mouse and rat models have been
developed [5]. In the present study we use a transgenic
rat model with a mutated Huntingtin gene containing
51 CAG repeats [6].
Thirdly, several animal models have been designed to
mimic human stroke as close l ya sp o s s i b l ei no r d e rt o
test possible reparative effects and neuroprotective
therapies [7]. Here, we use a model of focal ischemia by
the systemic injection of a photoactive dye (Rose Bengal)
in combination with visible light irradiation of the sen-
sorimotor cortex. As with the 6-OHDA model, this
lesion is usually applied to only one brain hemisphere
leading to left-right motor imbalances in the lesioned
animal.
The Catwalk method is an automated and computer-
ized gait-analysis technique that allows objective quanti-
fication of multiple static and dynamic gait parameters.
This method has previously been evaluated for use in
animal models of pain [8,9], sciatic nerve injury [10,11]
and arthritis [12,13], but not yet in animal models
of CNS based movement disorders. Therefore, the aim
of the study is to evaluate the suitability and sensitivity
of the Catwalk method for behavioral characterization of
different animal models of PD, HD and stroke.
Results
a. 6-OHDA model
As i n g l ed o s eo f6 - O H D A( 8μg) was administered for
the MFB group, two doses were tested for the STR
injections (partial lesion group with 10 μg and full lesion
group with 20 μg). Experimental groups were tested
behaviorally in the cylinder test and using the catwalk
method according to Fig. 1. Fig. 2A-C, show the histolo-
gical confirmation of lesion size at 4 weeks post-
injection after immunostaining of tyrosine hydroxylase
(TH) positive dopaminergic fibers in the striatum. The
loss of dopaminergic fibers in the caudate putamen was
quantified stereologically via the Cavalieri method, and
expressed as a percentage of total caudate putamen
volume (Fig. 2D). The lesion size varied between 82.80%
(s.e.m. 10.54) in the MFB group, 75.67% (s.e.m. 14.77) in
the STR high group and 60.40% (s.e.m. 11.41) in the
STR low group. Sham operated rats showed no loss in
TH immunoreactivity (data not shown).
The cylinder test confirmed the lesioning behaviorally.
Lesioned animals of the STR high and MFB groups
showed a deficit in usage of the paw contralateral to the
lesion both at 3 days and 2 weeks post-injection
(Fig. 3A). This deficit was smaller in the STR low group
and was statistically significant only for the early time
point. Using the means and variances of the paw usage
in the different groups, we determined that the minimal
sample size required to detect significant differences
(a < 0.05, 1-b > 0.8, effect size 25) was N = 5 for the
STR low group and N < 3 for the 2 other 6-OHDA
lesion groups.
Gait analysis parameters collected by the Catwalk sys-
tem were first analyzed in the group showing the great-
est extent of lesion, the MFB group. Significant
contralateral (’lesioned’ paw) vs. ipsilateral (’non-
lesioned’) differences were observed in the forepaws for
the parameter ‘intensity’ at both time points (contralat-
eral < ipsilateral, Fig. 3B). In the corresponding sham
group, the ‘intensity’ parameter showed no significant
contralateral-ipsilateral differences. Using the means and
variances of the pawprint intensity imbalance measured
for the MFB lesion group, we determined that the mini-
mal sample size required to detect significant effects is
N = 3. Other parameters showed no significant differ-
ences between paws contralateral to the lesion com-
pared to paws ipsilateral to the lesion, with the
exception of the parameter ‘max area’ (forepaws, at 1
week time point, contralateral < ipsilateral, ratio -12.1%
s.e.m. 1.3, p < 0.05), and contact % (forepaws, at 2 week
time point, contralatreral > ipsilateral, ratio + 43.5% s.e.
m. 4.5, p < 0.05) (data not shown). No significant
contralateral-ipsilateral differences were observed in the
hindpaws in the MFB group.
Figure 1 Experiment time line for gait analysis in 6-OHDA PD model in rats. Lesioned and control rat groups were prepared as described
in materials and methods. Experimental groups were tested for motor deficits via automated gait analysis or via limb use asymmetry test
(cylinder test) at indicated time points. Brains of animals were perfused at 4 weeks post-injection for histological analysis. *, measurement in
striatal lesion groups only.
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the striatum, ‘intensity’ was significantly different
between contralateral and ipsilateral forepaws starting at
week 1 post-injection for the STR high 6-OHDA group
and at 2 weeks for the STR low 6-OHDA group (Fig. 3C).
Intensity (at 1 week, p < 0.01, and 2 weeks and 3 weeks, p
< 0.05) as well as max area (at 2 weeks, p < 0.05) were
also significantly different for hindpaws (contralateral
< ipsilateral) in the STR high 6-OHDA group (data not
shown). Sample size analysis using means and variances
of pawprint intensity imbalance for these experimental
groups yielded minimal sample sizes of N = 4-6. In the
group having received a sham injection in the striatum,
the ‘intensity’ parameter showed no significant contralat-
eral-ipsilateral differences although variability was high
(Fig. 3C, p = 0.18 - 0.56). No other parameters showed
significant contralateral-ipsilateral differences (data not
shown), and locomotor speed was not different between
lesion and sham animals (Additional file 1).
b. Rat transgenic model for Huntington’s disease
Motor coordination and balance of 2- and 5 months old
tgHD and WT rats were measured using the rotarod
test. Throughout the study, there was no significant
between-group difference in the latency to fall off
the rotarod at all 5 speeds and ages tested (Additional
file 2A), consistent with the asymptomatic description
given in previous studies [14].
However, when gait abnormalities measured by the Cat-
walk method were assessed monthly, 2-month-old homo-
zygous tgHD rats showed a significant increase in the
swing speed of the hindpaws and right forepaw as com-
pared to their wild-type littermates (Fig. 4A; all p < 0.03;
min. sample size needed: N = 5-8), while the duration of
Figure 2 Histological analysis of 6-OHDA lesioned rats. Tyrosine hydroxylase (TH) immunohistochemistry reveals loss of TH staining in the
striatum of the lesioned hemisphere following striatal lesion using 10 μg (A) or 20 μg (B) 6-0HDA or following 6-OHDA lesioning of the medial
forebrain bundle (C). (D) Cavalieri quantification of the proportion of TH immunoreactivity retained in the caudate putamen for the separate 6-
OHDA experimental groups, as well as the sham group. Data are shown as mean ± s.e.m. Scale bar, 1 mm.
Vandeputte et al. BMC Neuroscience 2010, 11:92
http://www.biomedcentral.com/1471-2202/11/92
Page 3 of 11paw contact was significantly decreased (Fig. 4B; all p <
0.02; min. sample size needed: N = 3-6). Locomotor speed
was also significantly higher for 2 month old tgHD rats
compared to controls (Additional file 1). Although other
parameters did not reach statistical significance, this trend
(p ≤ 0.10 for three out of four paws) was also seen in an
increase in stand index (the speed at which the paws lose
contact with the glass plate) (Fig. 4C) and a decrease in
swing (the duration of no contact with the glass plate in a
step cycle) (Fig. 4D). However, the differences in speed
disappeared at the later time points investigated (Addi-
tional file 3).
In addition, with increasing age, 3- and 4-month-old
tgHD rats started to develop a deviating gait pattern, in
which they placed the right forepaw under a smaller
angle, i.e. more to the inside, than wild-type rats (Fig. 5;
all p < 0.03; min. sample size needed: N = 2-7). This
deviating gait pattern normalized at the age of 5 months.
No significant differences in paw angle were detected
between the different time points investigated within
each group.
c. Photothrombotic stroke model
As stroke model, we induced focal ischemia by the sys-
temic injection of a photoactive dye (Rose Bengal) in
combination with visible light irradiation of the sensori-
motor cortex. A representative cresyl violet staining,
revealing the stroke location of all photothrombotic rats
is shown in Fig. 6A. All these animals were tested for
their motor behavior and usage of the paws via the
rotarod test, cylinder test and the Catwalk. The cylinder
test showed a significant deficit in the usage of the fore-
paws contralateral to the lesion site 48 h after surgery
(Fig. 6B; p = 0.029, minimal sample size determination:
N < 3). Furthermore the results of the rotarod test sug-
gested a discrepancy in usage, equilibrium and motor
coordination of the stroke animals compared to the con-
trols although no significance was reached (data not
shown). 1 day after surgery the animals were tested on
the Catwalk. Differences were found in intensity of the
contralateral hindlimbs compared to the ipsilateral
hindlimbs (Fig. 7A; p < 0.05). Linked to these results a
significant difference was also observed in the print
area, print width and max area parameters. All these
parameters showed lower values for the contralateral
hindlimbs in comparison to the ipsilateral hindlimbs
( F i g .7 B ,Ca n d7 D ;p<0 . 0 5 ;m i n .s a m p l es i z en e e d e d :
N = 2-5). These differences were not present in the
forepaws. No contralateral-ipsilateral asymmetry was
observed in the sham operated animals, and locomotor
speed was not different between lesion and sham ani-
mals (Additional file 1).
Discussion
In this study we measured locomotor deficits in rat
models of PD, HD and stroke using a novel automated
gait analysis test, the catwalk method, and compared the
results to deficits recorded using established behavioral
motor tests. To the best of our knowledge, the present
study is the first to evaluate these rat models of neurolo-
gical disorders using an automated gait analysis concur-
rently measuring static and dynamic gait parameters.
Figure 3 Motor deficits following unilateral lesioning in rat
basal ganglia using 6-OHDA. (A) Proportion of limb use of
‘lesioned’ paws in 6-OHDA experimental groups as well as in normal
rats and sham controls as measured in the limb-use asymmetry
(’cylinder’) test. Dashed line at 50% indicates the average expected
paw usage in normal rats. (B) Deficits in pawprint intensity recorded
via the catwalk method (expressed as % difference of contralateral
vs. ipsilateral forepaws) in 6-OHDA medial forebrain bundle lesion or
sham rats at 1 and 2 weeks post-lesion. (C) Deficits in pawprint
intensity recorded via the catwalk method (expressed as %
difference of contralateral vs. ipsilateral forepaws) in 6-OHDA striatal
lesion or sham rats at 3 days, 1, 2 and 3 weeks post-lesion. Data are
shown as mean ± s.e.m. * p < 0.05.
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Page 4 of 11Figure 4 Catwalk automated gait analysis test of tgHD and littermate control rats at two months of age. (A) Shows the swing speed of all
limbs for tgHD (light) and control rats (dark). (B) Duration of paw contact of all limbs for tgHD and control rats. (C) Speed at which the limbs lose
contact with the glass plate for tgHD and control rats. (D) Swing time of all limbs for tgHD and control rats. Data are shown as mean ± s.e.m. * p < 0.03.
Figure 5 Catwalk automated analysis of paw angle placement of tgHD and normal rats between 2 and 5 months of age. At 3 and 4 months
the right forepaw angle placement of the tgHD rats was deviated in comparison to the wild-types. Data are shown as mean ± s.e.m. * p < 0.03.
Vandeputte et al. BMC Neuroscience 2010, 11:92
http://www.biomedcentral.com/1471-2202/11/92
Page 5 of 11The quantitative gait analysis used in the present
study, the catwalk method, provides both static gait
parameters as well as time-based information and a
pressure parameter, in contrast to a conventional gait
analysis test, such as the analysis of footprints obtained
by allowing rodents to walk with inked paws along a
sheet of paper, which provides information about static
gait [15]. The 6-OHDA rat model for PD recapitulates
one of the main features of PD, namely the loss of mid-
brain dopaminergic neurons. The loss of dopaminergic
innervation of the caudate putamen leading to reduced
activity of the basal ganglia thalamocortical motor cir-
cuit and motor deficits has been well characterized both
in the rat 6-OHDA model as well as in the human dis-
ease [2,16,17]. One of the most sensitive rodent beha-
vioral tests available to assess midbrain dopaminergic
cell loss is the amphetamine induced rotation test; how-
ever a pharmacological challenge is necessary to induce
the behavioral readout [18]. It has proved challenging in
the field to develop behavioral readouts for dopaminer-
gic cell loss without pharmacological challenge [2]. The
‘cylinder’ test (paw use asymmetry test) can be used to
observe contralateral-ipsilateral motor imbalances in the
forelimbs in unilaterally 6-OHDA lesioned animals with-
out pharmacological challenge [19], as is confirmed in
our experimental groups where the degree of impair-
ment correlates to the degree of lesion (Fig. 2D). This
contralateral-ipsilateral imbalance is also observed in the
gait analysis, as the intensity of the lesioned forepaw is
significantly lower compared to the non-lesioned paw,
indicating that the 6-OHDA lesioned animals preferably
use the non-lesioned paws to support their body weight.
The amplitude of the intensity imbalance was consistent
with the severity and type of lesion. Indeed, strongest
measures were observed for the group showing the lar-
gest lesion, the MFB lesion group. In this group, strong
paw intensity deficits were seen at 1 week post-lesion.
On the contrary, striatal injections which yielded lower
levels of dopaminergic fiber loss showed lower pawprint
intensity deficits compared to the MFB group. A recent
study has similarly analyzed 6-OHDA lesioned rats
using the Catwalk gait analysis [20], including experi-
mental groups with mild bilateral 6-OHDA lesions in
the striatum combined with subthalamic nucleus stimu-
lations. Because Vlamings et al. [20] performed bilateral
lesions and our major observation is a contralateral-
ipsilateral imbalance in pawprint intensity, it is difficult
to draw parallels between both studies. We nevertheless
observed that the contralateral-ipsilateral imbalances
were bigger in the forepaws compared to the hindpaws,
similar to differences of effects of forepaw vs hindpaw
as observed by Vlamings et al. [20].
Interestingly, despite the availability of multiple para-
meters from the catwalk analysis, the only parameter
which consistently yielded results corresponding to a
unilateral motor deficit was the intensity parameter
measured for the forepaws. This parameter is highly
analogous to the paw usage parameter monitored in the
cylinder test and we can therefore conclude that infor-
mation obtained from motor behavior assessment of
hemiparkinsonian rats using the catwalk test is compar-
able to that obtained by the cylinder test.
We have also monitored the onset and early progres-
sion of HD-like symptoms related to all motor systems
affected in HD in a transgenic rat model of HD. In line
with previous studies in this tgHD rat and in a knock-in
mouse model of HD [14,21], gait analysis revealed a
hyperkinetic profile early on in the pre-symptomatic
Figure 6 Photothrombotic stroke model. (A) Shows a representative cresylviolet staining of the photothrombotic stroke region. The limb use
asymmetry test (B) showed a significant deficit in the usage of the forepaws contralateral to lesion site of stroke animals in comparison to the
sham animals. Data are shown as mean ± s.e.m. * p = 0.029. Scale bar, 1 mm.
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open field monitoring [14,21], we have demonstrated by
the aid of the Catwalk that the hyperkinetic profile in 2-
month-old transgenic rats is more specifically reflected
by increased swing speed and decreased paw contact of
quasi all limbs, and lasts until the age of 3 months; the
latter in accordance with a previous report [14]. 2-
month-old transgenic rats also showed increased loco-
motor speed (Additional file 1), in line with previously
described negative correlation between locomotor speed
and stance duration [22]. This early hyperkinetic profile
was not observed on the rotarod test used as a reference
test in this study, allowing us to conclude that the cat-
walk method is more sensitive in measuring behavioural
deficits in these animals than the rotarod test (Addi-
tional file 2A) [23]. Whether alternative behavioural
tests, of which some perform better than the rotartod,
e.g. the balance beam tasks, will also detect this hyperki-
netic profile needs to be further studied ([24-26]).
Consistent with observations in humans, in which
even years before the onset of overt motor symptoms
such as chorea, subtle motor deficits are present (i.e
alterations in finger-tapping rhythm and rate) [27,28],
we also noticed in 3- and 4-month-old tgHD rats a devi-
ant gait pattern, in which they placed the right forepaw
more to the inside than WTs (Fig. 5). No significant dif-
ferences in paw angle were observed between the time
points of both groups.
Figure 7 Catwalk automated gait analysis of rats with a photothrombotic stroke compared to sham operated animals.E x p e r i m e n t a l
groups were prepared and submitted to catwalk gait analysis as described in Materials and Methods. Depicted are mean ratios (± s.e.m.) of
pawprint intensity (A), print area (B), print width (C) and max area (D) parameters of stroke animals vs. sham operated animals for each limb. All
parameters showed lower values for the contralateral hindlimbs in comparison to the ipsilateral hindlimbs. * p < 0.05.
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described in symptomatic mice transgenic for HD and in
3-NP-treated mice [15,29]. Specifically, R6/2 transgenic
mice at 13-14 weeks of age exhibited a gait that lacked a
normal, uniform, alternating right-left step pattern with
inside paw placement of all limbs, although within 3-NP-
treated mice, the paw placement angle of the hind limbs
was more open [15,29]. The unilateral onset of this paw
angle placement phenotype in the tgHD rats may be
explained by reports suggesting that asymmetric striatal
degeneration due to ventricle enlargement is not uncom-
mon [6]. Whether the paw angle measured using the cat-
walk is indeed an early marker for motor deficits needs
to be clarified in further longitudinal designs.
Thirdly, we used the Catwalk method to quantify distur-
bances in gait in rats with a unilateral photothrombotic
lesion in the parietal sensorimotor cortex compared to
sham operated animals. As for the tg HD animals, the
rotarod test which we used as a reference test proved to
be insensitive since only a fraction of the lesioned rats fell
off the machine (Additional file 2B). As expected by the
anatomofunctional location of the infarct, the rats showed
a deficit in usage of the forepaw contralateral to the lesion
48 h after surgery as seen with the cylinder test. However,
this test is not suitable for the detection of impairments in
the hindpaws. In contrast, the gait analysis with the Cat-
walk method demonstrated a significant difference in the
usage of the contralateral vs. ipsilateral hindlimbs. This
was expressed by the ‘intensity’, ‘print area’, ‘print width’
and ‘max area’ parameters (Fig. 7). All these parameters
showed that the lesioned animals put a higher pressure on
the non-affected ipsilateral hindpaw than the contralateral
hindpaw. This imbalance is likely due to a compensation
of the animal to spare the affected paw and enforce the
paw with non-injured motoric excitation. These results
confirm data where cortical ablation lesions impaired the
performances of the rats on a beam walking task caused
by hindlimb deficits [30,31]. Our data therefore clearly
demonstrate the advantage of using automated gait analy-
sis for the study of cortically lesioned rats.
Although the present study has focused on gait analysis
in rats, extension to mouse models is in principle possible.
For example, robust effects on stride length during continu-
ous locomotion following pyramidotomy of the cortical
tract in adult mice have been observed [32,33]. Also,
unsteady gait with strongly reduced paw print area for both
fore- and hindpaws and reduced base of support for the
hindpaws have been measured in a mouse model for
Refsum disease [34]. Further research will be required to
delineate gait deficits in mouse models of PD, HD or stroke.
Conclusion
In the present study, we measured for the first time gait
deficits in rat models of PD, HD and stroke using an
automated quantitative gait analysis test and compared
the results to motor deficits observed in reference tests.
In the unilateral 6-OHDA lesion model for PD, the defi-
cits in gait essentially confirmed results obtained by the
cylinder test. However, in the HD model and the stroke
model the Catwalk analysis proved more sensitive than
the rotarod test and also added new and more detailed
information on specific gait parameters. The automated
quantitative gait analysis test may thus be a useful tool
to study both motor impairment and recovery associated
with various neurological motor disorders.
Methods
Animals and surgery
Animals were housed under 12 h light/12 h dark cycle
with free access to food and water. All animal experiments
were performed in accordance with national and interna-
tional regulations and approved by the animal care and
use committee of the K.U. Leuven. For the 6-OHDA and
stroke model, animals were anesthetized before surgery
with a ketamine (Ketalar®, Pfizer 60 mg/kg) and medeto-
midin (Domitor®, Orion Pharma, 0.4 mg/kg ip) cocktail.
Anesthesia was reversed with atipamezol (Antisedan®,
O r i o nP h a r m a ,1m g / k gi p )a tt h ee n do ft h es u r g i c a l
procedures.
6-OHDA lesion
8 weeks old female Wistar rats (Janvier, Le Genest Saint
Isle, France) were divided into different groups: animals
with a unilateral lesion (striatal injection of 10 or 20 μg
6-OHDA (n = 5 per group), or medial forebrain bundle
injection of 8 μg 6-OHDA (n = 5), all in 4 μl 0.9% NaCl
containing 0.05% ascorbic acid, Sigma), sham-operated
animals (n = 5 each for striatum and medial forebrain
bundle, injected with 0.9% NaCl containing 0.05% ascor-
bic acid, Sigma Aldrich, Bornem) and control animals
(n = 5). The striatal injections were performed at the
following coordinates relative to Bregma: anteroposterior
(AP) 0 mm, lateral (LAT) -2.8 mm and dorsoventral
(DV) -5.5 mm [19]; coordinates for the medial forebrain
bundle were AP -3.4 mm, LAT -1.6 mm and DV -8.2
mm [35]. Animals were placed in a stereotactic head
frame (Stoelting, IL, USA) and the 6-OHDA or control
solution was administered with a 30-gauge needle and a
Hamilton syringe at a rate of 0.50 μl/min. The 6-OHDA
solution was freshly prepared and protected from light
to minimize oxidation.
Rat transgenic model for Huntington’s disease
We investigated 14 male homozygous transgenic (tgHD)
rats (+/+) and 9 littermate controls (generous gift from
Prof. Olaf Riess, University of Tübingen, Germany). The
animals have a Sprague-Dawley background and all rats
were genotyped by Southern blot analysis of genomic
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the age of three weeks. At the age of approximately one
month, the animals were transferred to the Molecular
Small Animal Imaging center (MoSAIC) of the KULeu-
ven, Belgium. Gait analysis was performed monthly for
animals starting from the age of approximately 2
months until 5 months. In this stage, the animals are
presymptomatic when evaluated with standard beha-
vioral tools [14].
Phototrombotic stroke model
8 week old male Wistar rats (n = 8, Janvier, Le Genest
Saint Isle, France) were divided into two groups: 5 ani-
mals received a cortical stroke and 3 animals were sham-
operated. Cortical ischemia was induced by the use of a
photothrombotic stroke approach [36]. Photo illumina-
tion with green light (wavelength 540 nm; bandwidth 80
nm) was achieved using a Xenon lamp with heat-
absorbing and green filters. The irradiation at intensity of
0.68W/cm
2 was directed with a 3 mm optic fiber, which
was placed on the exposed skull above the right sensory-
motorcortex. Photo illumination was performed during
20 min. after intravenous injection of the photosensitizer
Rose Bengal (20 mg/kg) in a tail vein [37]. The photooxi-
dation causes endothelial damage, platelet activation, and
finally vascular occlusion [38]. We chose this model
because of its possibility to induce an ischemic lesion in
any desired cortical area and because it is one of the least
invasive stroke models. The sham-operated animals
underwent the same operation procedure however the
photo illumination with the green light was omitted.
Histological assessment and stereological quantification
of the 6-OHDA lesion
6-OHDA rats were deeply anesthesized with pentobarbi-
tal and transcardially perfused with saline followed by
ice cold 4% paraformaldehyde in phosphate buffered sal-
ine (PBS). After removal of the brain and overnight
postfixation, 50 μm thick coronal sections were made
using a vibratome (Microm, Walldorf, Germany). For
immunohistochemistry floating sections were treated
with 3% H2O2 to remove endogenous peroxidase activ-
ity, washed and incubated with an antibody raised
against tyrosine hydroxylase (rabbit, 1:1000, Chemicon,
Temecula, CA, USA) in 10% goat serum. After washing,
the sections were incubated with biotinylated swine
anti-rabbit antibody, followed by incubation with strep-
tavidin horseradish peroxidase complex (DAKO). Immu-
noreactivity was visualized using 3,3’ diaminobenzidine.
In all rat brains, the needle tract was identified to verify
correct positioning of the infusion needle.
T h ev o l u m eo fl e s i o ni nt h ec a u d a t ep u t a m e n( T H -
negative region) was determined by stereological investi-
gation using the Cavalieri method (Stereoinvestigater;
MicroBrightField, Magdeburg, Germany) as previously
described [39]. The values for the lesioned hemisphere
were expressed as a percentage of the total volume of
the caudate putamen.
Histological assessment of the stroke lesions
After behavioral testing, brains of stroke rats were per-
fused as described above for 6-OHDA rats. Cresyl violet
staining was used to visualize the stroke region. For this,
50 μm thick coronal slices were mounted on microscope
slides and covered with 0.5% cresyl violet for 5 min.
Slices were rinsed with 0.05% acetic acid.
No histological analysis has been performed on the
tgHD rats and wild-type littermates, as they were also
used in other studies, where later time points were aimed.
Behavioral tests
Limb use asymmetry test (Cylinder test)
The cylinder test was used as a reference test to quan-
tify the use of the forelimbs of the 6-OHDA lesion and
stroke animals in comparison to the sham-operated ani-
mals. The test was performed essentially as previously
described [19]. Briefly, the animals were placed in a 20
cm wide transparent glass cylinder and a minimum of
25 contacts of the forepaw with the wall of the glass
cylinder were recorded. The number of impaired fore-
limb contacts (the contacts of the limb on the side of
the body contralateral to the lesioned or sham treated
side of the brain) was expressed as a percentage of total
forelimb contacts. This value was compared to the theo-
retical value of 50% whereby both paws are used equally.
Control animals score around 50% in this test [40].
Rotarod
To assess effects on motor coordination between tgHD
and wild-type animals, rats were trained to remain on a
rotarod. All rats underwent a 3-day training program on a
7 cm diameter rotarod (Ugo Basile, Biological Research
Apparatus, Varese, Italy). During the training period, each
rat was placed on the rotarod at a constant speed (8 rota-
tions per minute; rpm) for a maximum of 120 sec, and the
latency to fall off the rotarod within this time period was
recorded. Rats received four trials per day for three conse-
cutive days, by which time a steady baseline level of per-
formance was attained. The test consisted of two trials at
5 increasing speed levels, ranging from 8 rpm to 16 rpm.
The mean latency to fall of the rotarod at each speed level
was recorded. The same training procedure was used for
the animals that endured a photothrombotic stroke. All
animals were trained for 3 days, and were then tested at
increasing speeds the day after surgery.
Catwalk quantitative gait analysis test
The Catwalk™ is a video-based analysis system to assess
gait in voluntarily walking mice or rats (Noldus, Wagen-
ingen, The Netherlands). The Catwalk system objectively
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ner. The principle of this method is based on an optical
technique. The light of a fluorescent tube is completely
internally reflected in the glass walkway floor. When the
animal crosses the walkway the light leaves the glass
and illuminates only the areas of contact. In this way
the different paw contacts are visualized. Based on the
position, pressure, and surface area of each footfall, mul-
tiple parameters are calculated: intensity of the paws
(signal depends on the degree of contact between a paw
and the glass plate and increases with increasing pres-
sure), print length (length (horizontal direction) of the
complete print), print width (width (vertical direction)
of the complete paw print), print area (surface area of
the complete print), stand (duration of contact of a paw
with the glass plate in a step cycle), swing (duration of
no contact with the glass plate in a step cycle), swing
speed (speed of the paw during swing), stand index
(measure for the speed at which the paw loses contact
with the glass plate), stride length (the distance between
successive placements of the same paw), angle (estimate
of the angle (in degrees) of the paw axis relative to the
horizontal plane). Locomotor speed was determined by
dividing the covered distance on the runway (cm) by the
time needed to cross it [22].
Because data acquisition is dependent upon the ani-
mals walking across the runway, one issue we had to
take into account in the present study is the altered
mobility or motivation to walk in animal models of
movement disorders. Indeed, we noted that disease
model animals showed reduced motivation to cross the
test runway upon repeated testing. However, we found
that a single 2 minute acclimatization session prior to
lesioning procedures (for 6-OHDA and stroke) or early
in life (HD model) was sufficient for successful crossings
of the runway during the experiment itself. For data col-
lection, three runs per animal and time point were per-
formed by placing the animal in front of the start zone
of the catwalk runway. Analysis was performed on a
minimum of 4 normal step sequence patterns in each
uninterrupted run.
Statistics
For the cylinder test of the 6-OHDA and sham
injected animals, percentages of paw usage in each
group were compared to the theoretical value of 50%
using a one-tailed Wilcoxon signed rank test. In the
comparisons of the unilaterally 6-OHDA lesioned ani-
mals, ratios of values from contralateral paws vs. ipsi-
lateral paws were taken for all catwalk parameters and
represented as percentage difference between both
paws. These ratios were tested for significant difference
from 0 using the one-tailed Wilcoxon signed rank test.
Catwalk parameters collected from stroke animals were
normalized for each paw using values collected from
sham operated animals. The values were expressed
relative to the control mean [(stroke/control mean)-1]
and were tested for significant difference between con-
tralateral paws and ipsilateral paws using the one-tailed
Wilcoxon signed rank test. Behavioral outcomes of
tgHD animals were compared to wild-type littermates
using the non-parametric Mann-Whitney U test. Using
the means and variances of the parameters measured
in the different experiments, we determined the mini-
mal sample size required to detect significant differ-




significance level a < 0.05, power 1-b >0 . 8 ,o n e - t a i l e d
test, s = standard deviation, δ =e f f e c ts i z e ) .C o n v e n -
tional statistics were carried out using STATISTICA
v8.0 (Statsoft, Tulsa, OK, USA) or Graphpad Prism 3.0
(San Diego, CA, USA). Statistical significance was set
at p < 0.05.
Additional material
Additional file 1: Locomotor velocities for each experimental group.
Velocities are expressed as centimeters traveled per second. Results of
statistical comparisons between model animals and respective control
animals are given in column 4.
Additional file 2: Shows the results of the Rotarod test performed
on tgHD (A) and photothrombotic stroke rats (B) compared to
control animals. Experimental groups were prepared and submitted to
rotarod analysis as described in Methods. Shown are latency to fall off
the rotarod at different rotation speeds (8-16 rpm) using a session time
of 120 seconds. Data are shown as mean ± s.e.m., In B none of the
control animals fell during the imparted session time.
Additional file 3: Catwalk automated gait analysis test of tgHD and
littermate control rats at three and four months of age.( Aa n dB )
Show the duration of paw contact of all limbs for tgHD (light) and
control rats (dark). (C and D) represent the swing speed of the same
animals.
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